• Beta Bionics launched a public dashboard publishing near real-time real-world performance data for its iLet Bionic Pancreas.
• The data is available now, ahead of the American Diabetes Association’s 86th Scientific Sessions in June, where it will be referenced.
• Beta Bionics framed the move as a transparency push designed to help clinicians compare automated insulin delivery options using ongoing outcomes.
• The dashboard covers all users meeting two pre-set criteria, aiming to reduce selective reporting and support broader evaluation by stakeholders.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606020900PRIMZONEFULLFEED9730300) on June 02, 2026, and is solely responsible for the information contained therein.